---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-177288"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:16:15.988330+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Two directors resign from Apogee board; board shrinks from 9 to 7

## Summary
- Andrew Gottesdiener, M.D. and Peter Harwin notified Board of resignations effective May 11, 2026.
- Resignations are not due to any disagreement with Company's operations, policies or practices.
- Board size will be reduced from nine to seven directors effective May 11, 2026.
- No replacements announced; CEO Michael Henderson remains in role.

## SEC filing metadata
- accession: 0001193125-26-177288
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/0001193125-26-177288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/apge-20260421.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-177288
- JSON: https://secwatch.observer/filing/0001193125-26-177288.json
- Plain text: https://secwatch.observer/filing/0001193125-26-177288.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.